N Ihlemann
Overview
Explore the profile of N Ihlemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ostergaard L, Lauridsen T, Iversen K, Bundgaard H, Sondergaard L, Ihlemann N, et al.
Clin Microbiol Infect
. 2020 Feb;
26(8):999-1007.
PMID: 32036048
Background: Transcatheter aortic valve implantation (TAVI) has been approved for the treatment of severe aortic stenosis since 2008 and recent trials have shown that TAVI is at least non-inferior to...
2.
Korshin A, Gronlykke L, Nilsson J, Moller-Sorensen H, Ihlemann N, Kjoller M, et al.
Int J Cardiovasc Imaging
. 2018 Feb;
34(7):1017-1028.
PMID: 29383465
Tricuspid annular plane systolic excursion (TAPSE) is a robust measure of RV function, but the performance of transesophageal echocardiography (TEE) measured TAPSE during surgery is not well established. We aim...
3.
Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update
De Backer O, Arnous S, Ihlemann N, Vejlstrup N, Jorgensen E, Pehrson S, et al.
Open Heart
. 2014 Oct;
1(1):e000020.
PMID: 25332785
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. One of its most devastating complications is the development of thromboembolism leading to fatal or disabling...
4.
Major-Pedersen A, Ihlemann N, Hermann T, Christiansen B, Kveiborg B, Dominguez H, et al.
Horm Metab Res
. 2008 Sep;
40(9):607-13.
PMID: 18792871
The aim of the study is to determine if attenuation of postprandial hyperglycemia, by acutely and chronically enhancing postprandial insulin secretion in insulin-resistant individuals, improves the endothelial dysfunction. We assessed...
5.
Major-Pedersen A, Ihlemann N, Hermann T, Christiansen B, Dominguez H, Kveiborg B, et al.
Exp Diabetes Res
. 2008 Mar;
2008:672021.
PMID: 18350125
Background/aims: Postprandial hyperglycemia, an independent risk factor for cardiovascular disease, is accompanied by endothelial dysfunction. We studied the effect of oral glucose load on insulin and glucose fluctuations, and on...
6.
Hermann T, Rask-Madsen C, Ihlemann N, Dominguez H, Jensen C, Storgaard H, et al.
J Clin Endocrinol Metab
. 2003 Mar;
88(3):1252-7.
PMID: 12629115
Low birth weight has been linked to insulin resistance and cardiovascular disease. We hypothesized that insulin sensitivity of both muscle and vascular tissues were impaired in young men with low...
7.
Ihlemann N, Stokholm K, Eskildsen P
Diabet Med
. 2002 Jun;
19(6):476-81.
PMID: 12060059
Background: Type 2 diabetes is associated with an increased risk of cardiovascular disease. Endothelial dysfunction is thought to be an early marker of atherosclerosis. The purpose of this study was...
8.
Rask-Madsen C, Ihlemann N, Krarup T, Christiansen E, Kober L, Nervil Kistorp C, et al.
Diabetes
. 2001 Oct;
50(11):2611-8.
PMID: 11679442
Blunted insulin-stimulated endothelial function may be a mechanism for the development of atherothrombotic disease in type 2 diabetes, but it is unknown whether hypoglycemic drug therapy can modulate this abnormality....
9.
Nielsen H, De Palo E, Meneghetti M, Madsen P, Ihlemann N, Secher N
Regul Pept
. 2001 Jun;
99(2-3):203-7.
PMID: 11384783
The circulating immunoreactive atrial natriuretic peptide (C-terminal; alpha-ANP) increases during exercise to become suppressed in the first hours of the recovery. The response of the N-terminal ANP fragments to acute...